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Prospective randomization is a fundamental feature of
clinical trial design because this process provides a mecha-
nism for equal distribution among treatment arms of all
factors, both recognized and hidden, that might modify
outcome. Although an acceptable substitute for random-
ization does not exist, in the area of endovascular therapy
for abdominal aortic aneurysm, practical considerations
often limit the use of randomization. In this regard, adjust-
ing for case severity mix provides a mechanism to obtain
some measure of confidence in comparing the outcomes of
two or more treatment protocols pursued within a single
clinical trial or reported by separate investigators. Relevant
examples include comparing outcomes of two or more
different devices undergoing separate clinical trials; analyz-
ing results of the same technical approach reported by
different investigators; and gauging the effect of an adjunc-
tive measure, improved device, or enhanced deployment
system. Thus, it would be inappropriate to compare the
outcomes of endograft repair between two studies if one
was populated with healthy patients and relatively small
aneurysms and the other treated more complex aneurysms
among patients with significant comorbidities. The objec-
tive of adjusting for case variability is best achieved with
severity scoring schemes incorporating all factors known to
affect the outcome being assessed. Although scoring
schemes that attempt to define the severity of associated
medical comorbidities and anatomic factors have been re-
ported for lower-extremity peripheral vascular1 and venous
disease,2 comparable systems that are appropriate for endo-
vascular aneurysm repair have yet to be proposed. In this
report, comorbidity and anatomic schemes are offered as an
initial effort to develop useful tools for the comparative
analysis of data related to endovascular treatment of aortic
aneurysms.
A GENERAL APPROACH FOR
CATEGORIZATION AND WEIGHTING OF
DISEASE SEVERITY
Optimally the design of a disease severity scoring
scheme should grade each of the factors known or generally
presumed to affect the outcome of endovascular repair and
combine these into an overall score. In principle, factors
affecting outcome can be separated into the following two
general groups: (1) anatomic factors that affect technical
success (successful access, accurate deployment, complete
exclusion) and its durability (freedom from endoleak and
secondary procedures); and (2) medical comorbidities that
influence systemic morbidity and initial and late mortality.
There is an advantage to scoring these two sets of factors
separately, so as to allow correlation with the reported rates
of technical success, persistent or recurrent endoleak, and
secondary intervention on the one hand, and morbidity and
mortality rates on the other. Use of such schemes, however,
dictates that factors be described in sufficient detail for use
of uniform grades, such as the Society for Vascular Sur-
gery/American Association for Vascular Surgery (SVS/
AAVS) 0 to 3 scale corresponding to absent, mild, moder-
ate, and severe. With the preceding considerations in mind,
a Comorbity Severity Score and an Anatomic Factor Sever-
ity Score are proposed. Scoring all of the factors affecting
outcome may seem complex when viewed in toto, but in a given
report, it is probably unnecessary for all scores to be included.
One need apply only those scores that pertain to the
outcome measures being investigated and reported, partic-
ularly those that affect an outcome for which a significant
difference is claimed. Nevertheless, all of the scoring schemes
are included in this report for the advantage of collecting
prospective data in a manner that facilitates later analysis.
RISK STRATIFICATION BASED UPON
COMORBID MEDICAL CONDITIONS: A
COMORBIDITY SEVERITY SCORE
Cardiac deaths, related primarily to coronary artery
disease, dominate the early and late mortality rates for both
open surgery and endovascular aneurysm repair, account-
ing for the majority of deaths. As a consequence, at least
seven scoring systems have been developed for assessing the
relationship of bundled clinical parameters as a measure of
cardiac risk. For example, Eagle’s five clinical “markers” of
cardiac disease (age70 years, diabetes, history or Q-wave
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evidence of previous myocardial infarction, prior conges-
tive failure, history of angina pectoris) have proved useful in
identifying high-risk patients but serve mainly to select
patients for additional cardiac testing.3,4 Moreover, in a
study of 125 vascular surgery patients, Lette et al5 found
that, of seven published scoring systems and 18 individual
clinical parameters, only diabetes and Detsky score corre-
lated with postoperative cardiac morbidity and death. The
limitation of these schemes and the need to account for
multiple comorbid conditions led to the development of
the APACHE score, which, unfortunately, has not been a
valid predictor of operative mortality. Likewise, although
the POSSUM system has been found to correlate with
mortality in one vascular surgery unit, its complexity and
use of intraprocedural data (eg, blood loss) have limited its
usefulness as a predictive score. The strength of the Amer-
ican Society of Anesthesiology classification system lies in
its simplicity; however, this scoring scheme has been faulted
for its reliance, in part, on subjective parameters. Thus, a
comorbidity severity score is recommended that represents
a modification of a risk factor score that has been featured in
prior SVS/AAVS reporting standards1 and related reports
(Table I). In this approach, each risk factor is graded and
reported separately with a framework for combining the
most significant factors into an overall global score.
DEFINITION, CATEGORIZATION, AND
GRADING OF AN INITIAL CLINICAL STATE
As a principle, all conditions presumed to affect re-
ported outcomes should be recorded and reported in any
study or trial. The comorbidities and scoring systems are
mainly intended to represent systemic factors that are likely
to affect major morbidity and mortality associated with
endovascular or surgical treatment of the aortic aneurysm.
A 0 to 3 scale for grading factor severity from absent to
severe offers uniformity and simplicity. Notably, the revised
SVS/AAVS cardiac score combines elements of Eagle’s
scheme but has been modified to include the results of
established screening tests, such as the dipyridamole thal-
lium perfusion scan, Holter monitor, and ejection fraction.
Pulmonary and renal disease have also been included in the
calculation of a comorbidity score, because both contribute
to procedure morbidity and mortality. Other risk factors
that warrant inclusion are hypertension and age. With these
in mind, a combined comorbidity severity scoring scheme
based upon the summation of weighted risks is offered
(Table II). Specifically, cardiac, pulmonary, and renal risk
factors are considered major components, whereas hyper-
tension and age are used as minor components. In recog-
nition of the dominant role cardiac risk plays in both early
Table I. SVS/AAVS medical comorbidity grading system
Score Description of score
Major components
Cardiac status
0 Asymptomatic, with normal electrocardiogram
1 Asymptomatic but with either remote myocardial infarction by history (6 months), occult myocardial
infarction by electrocardiogram, or fixed defect on dipyridamole thallium or similar scan
2 Any one of the following: stable angina, no angina but significant reversible perfusion defect on
dipyridamole thallium scan, significant silent ischemia (1% of time) on Holter monitoring, ejection
fraction 25% to 45%, controlled ectopy or asymptomatic arrhythmia, or history of congestive heart
failure that is now well compensated
3 Any one of the following: unstable angina, symptomatic or poorly controlled ectopy/arrhythmia
(chronic/recurrent), poorly compensated or recurrent congestive heart failure, ejection fraction
less than 25%, myocardial infarction within 6 months
Pulmonary status
0 Asymptomatic, normal chest radiograph, pulmonary function tests within 20% of predicted
1 Asymptomatic or mild dyspnea on exertion, mild chronic parenchymal radiograph changes,
pulmonary function tests 65% to 80% of predicted
2 Between 1 and 3
3 Vital capacity less than 1.85 L, FEV1 less than 1.2 L or less than 35% of predicted, maximal voluntary
ventilation less than 50% of predicted, PCO2 greater than 45 mm Hg, supplemental oxygen use
medically necessary, or pulmonary hypertension
Renal status
0 No known renal disease, normal serum creatinine level
1 Moderately elevated creatinine level, as high as 2.4 mg/dL
2 Creatinine level, 2.5 to 5.9 mg/dL
3 Creatinine level greater than 6.0 mg/dL, or on dialysis or with kidney transplant
Minor components
Hypertension
0 None (cutoff point, diastolic pressure usually lower than 90 mm Hg)
1 Controlled (cutoff point, diastolic pressure usually lower than 90 mm Hg) with single drug
2 Controlled with two drugs
3 Requires more than two drugs or is uncontrolled
Age
0 55 y
1 55-69 y
2 70-79 y
3 80 y
JOURNAL OF VASCULAR SURGERY
May 20021062 Chaikof et al
mortality and late mortality, the cardiac risk score is given a
quadruple weighting, the pulmonary and renal scores are
doubled, and the two “minor” components are singly
weighted. The maximum allowable comorbidity severity
score using this scheme is 30. Thus, scores can be divided
by 10 to yield a comorbidity severity score on a 3-point
scale, where, as previously stated, grades of 0 to 3 corre-
spond to absent, mild, moderate, and severe. A similar
approach has been applied throughout the anatomic scor-
ing schemes that follow.
RISK STRATIFICATION BASED ON VASCULAR
MORPHOLOGY: AN ANATOMIC FACTOR
SEVERITY SCORE
Anatomic characteristics determine the degree of diffi-
culty and potential success of all endovascular-based treat-
ment strategies. Anatomy influences delivery and deploy-
ment of the endoprosthesis, intraoperative imaging,
exclusion of the aneurysm, and durability of endograft
attachment, as well as long-term device integrity. As such,
anatomic and other local vascular factors are expected to
correlate with technical success, endoleak rate, migration,
conversion rate, and the need for secondary procedures.
Thus, standards for reporting the initial morphologic state
are required to compare and stratify outcomes. However,
categorization and grading of morphology, above all, must
balance a necessity for both detail and simplicity.
Rationale for grading system and task-specific cat-
egorization. The rationale for many of the parameters in
the developed categorization and grading system is based
primarily on suspected relationships between anatomy and
a specific outcome. With this in mind, we have avoided the
presentation of a scoring system that combines all aspects of
vascular morphology into a single global score, because
such an approach risks losing insight into those anatomic
characteristics that are most critical for a given task or
outcome. Thus, we present grading systems appropriate for
the scoring of distinct anatomical segments, as well as
discrete combinations of these scores relevant for tasks and
outcomes specific to the endovascular treatment of aortic
aneurysms (Table III). Finally, although anatomical assess-
ment can be performed using angiography, duplex or in-
travascular ultrasound scanning, or magnetic resonance
angiography, the proposed grading systems are based primar-
ily on data derived from computed tomography imaging.
It should be emphasized that the inclusion of all param-
eters and grading scales is not practical or necessary for
many reports that deal with endovascular treatment of
aneurysms. However, such schemes and measures are im-
portant when making comparisons or drawing conclusions
about specific aspects of endovascular repair that are known
to be affected by a particular anatomic factor. Thus, the
application of these schemes is necessarily selective. It is
acknowledged that both grading systems and schemes have
been derived on the basis of “best current opinion” and are
not based on correlations with the appropriate outcomes
using large databases. Thus, it is anticipated that correla-
tions with outcome will follow as clinical investigators test
these schemes. In turn, the data from these studies are
expected to provide the basis for future modification of
these schemes.
DEFINITION, GRADING, AND
CATEGORIZATION OF AN INITIAL
MORPHOLOGIC STATE
Aortic neck
Morphologic characteristics of the proximal aortic neck
influence the effectiveness of aneurysm exclusion and the
durability of endograft attachment.6,7 The proximal aortic
neck extends from the most caudal main renal artery to the
onset of the aneurysm, whereas the distal aortic neck is
defined as the segment of aorta between the aortic bifurca-
tion and the caudal-most portion of the aneurysm. Because
the intended site of endograft deployment may constitute
only a portion of available aortic neck, the aortic neck
grading scheme may be referenced to either a planned or
actual deployment site depending upon the objectives of
the investigation. For example, if the objective of the study
is to compare early type I endoleak rates between two or
more different devices or the technical success of the same
device in the hands of different investigators, grading the
available aortic neck for fixation or sealing on the basis of
the planned deployment site is recommended. The techni-
cal success rates, as a consequence, would reflect both
deployment accuracy and device performance. However, if
the investigation is directed at examining long-term device
stability or aneurysm exclusion after graft implantation, it is
recommended that morphologic grading be performed of
the actual deployment site. That is, scoring should be
performed of the achieved length of aortic neck used for
sealing and/or fixation. Schemes have appeared in which
neck morphology is described in terms of taper, reverse
taper, or bulging. Although the simplicity of this classifica-
tion is appealing, we believe its applicability to grading
anatomic severity is limited.
Definitions and scoring relevant to the aortic neck
region. An aortic neck scoring system is derived from a
consideration of several morphologic characteristics, in-
cluding the following: neck length (L) and diameter (d),
the angle between the flow axis of the suprarenal aorta
and the infrarenal neck (), the angle between the flow axis
of the infrarenal neck and the body of the aneurysm (),
and the amount of thrombus and calcification that are
present in the neck (Fig 1, A). The flow axis of the aneurysm
is defined as the line running from the proximal portion of the
aneurysm (or end of the aortic neck) to the aortic bifurcation.
Table II. Combined medical comorbidity severity
scoring scheme
Risk factor Weighting Score
Cardiac 4 12
Pulmonary 2 6
Renal 2 6
Hypertension 1 3
Age 1 3
Maximum score* 30
*Divide by 10 to restore 3-point scale.
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 5 Chaikof et al 1063
Proximal aortic neck length is scored as follows: 0, L
25 mm; 1, 15  L  25 mm; 2, 10  L  15 mm; 3, L 
10 mm. Proximal aortic neck angle ( or ) is scored as
follows: 0, angle 150°; 1, 150° angle 135°; 2, 135°
 angle  120°; 3, angle  120°. Proximal aortic neck
diameter is scored as follows: 0, d 24 mm; 1, 24 d 26
mm; 2, 26  d  28 mm; 3, d  28 mm. Calcification or
thrombus is scored as follows: 0, calcification  25% of
circumference, atheroma, or thrombus (2 mm thick) 
25% of circumference; 1, calcification 25% to 50% of cir-
cumference, atheroma, or thrombus (2 mm thick) 25% to
50% of circumference; 2, calcification  50% of circumfer-
ence, atheroma, or thrombus (2 mm thick)  50% of
circumference. Scoring the distal aortic neck, as it pertains
to implantation of aortic tube endografts, can be performed
using a similar grading scheme. However, angulation of the
distal neck () is defined as the angle between the flow axis
of the distal infrarenal neck and the common iliac artery.
Aneurysm dimensions and branch vessels
Aneurysm morphology may influence endograft deliv-
ery, deployment, and embolization risk, as well as long-
term device performance, including the potential for
achieving complete aneurysm exclusion. Admittedly, the
data pertaining to patency of aortic branch vessels, includ-
ing lumbar arteries and the inferior mesenteric artery
(IMA), and risk of endoleak are limited.
Definitions and scoring relevant to an aortic aneu-
rysm. The aortic tortuosity index (T) is defined as T 
L1/L2 where L1 is the distance along the central lumen line
between the lowest renal artery and the aortic bifurcation
(without deviation into saccular areas or blebs) and L2 is the
straight-line distance from the lowest renal artery to the
aortic bifurcation (Fig 1, B). The aortic angle (	) is the
most acute angle in the pathway between the lowest renal
artery and the aortic bifurcation. Ideally, both the aortic
angle and tortuosity index are measured from spatially-
correct three-dimensional data. They are scored as follows:
0, T 1.05 or an aortic angle (	) between 160° and 180°;
1, 1.05T 1.15 or	 between 140° and 159°; 2, 1.15
T  1.2 or 	 between 120° and 139°; 3, T  1.2 or 	 
120°. Thrombus is scored as follows: 0, no visible thrombus;
1, 25% of the cross-sectional area; 2, 25% to 50% of the
cross-sectional area; 3, 50% of the cross-sectional area. A
similar grading scheme can be used if common and external
iliac artery aneurysms are present (2 cm) and the magni-
tude of thrombus is graded for each iliac segment. Aortic
branch vessels are scored as follows: 0, no lumbar arteries,
IMA, or other branches visibly patent; 1, one patent lumbar
artery or IMA; 2, at least 2 patent branch vessels (lumbar
arteries or IMA), none 4 mm in diameter; 3, any one of
the following with at least 2 patent branch vessels—paired
lumbar arteries, low-resistance outflow vessel (uncovered
accessory renal artery), or IMA 4 mm in diameter.
Iliac artery
Iliac artery morphology is crucial to obtaining delivery
device access into the aorta, sealing the aneurysm from
systemic intraluminal pressure, and maintaining perfusion
to the pelvis and adjacent areas. Categorization and grading
are based on several characteristics—calcification, diame-
ter, angulation or tortuosity, and length using a 0 to 3 scale
Table III. Definition, grading, and categorization of an initial morphologic state
Attribute Absent  0 Mild  1 Moderate  2 Severe  3
Aortic neck
Length (L) L  25 mm 15  L  25 mm 10  L  15 mm L  10 mm
Diameter (d) d  24 mm 24  d  26 mm 26  d  28 mm d  28 mm
Angle  150° 150°  angle  135° 135°  angle  120° Angle  120°
Calcification/thrombus  25% 25-50%  50% –
Aortic aneurysm
Angulation and tortuosity
Aortic tortuosity index (T) T  1.05 1.05  T  1.15 1.15  T  1.2 T  1.2
Aortic angle (	) 160° to 180° 140° to 159° 120° to 139°  120°
Thrombus 0  25% 25%-50% 50%
Aortic branch vessels No vessels 1 lumbar/IMA 2 vessels 2 vessels
d  4 mm IMA d  4 mm
Pelvic perfusion Patent bilateral IIA Single IIA occlusion Single IIA occlusion Bilateral IIA occlusion
Contralateral IIA  50%
stenosis
Iliac artery
Calcification None 25% vessel length 25%-50% vessel length 50% vessel length
Diameter/occlusive
disease
d  10 mm 8  d  10 mm 7  d  8 mm d  7 mm
No occlusive disease No stenosis7 mm
diameter or3 cm long
Focal stenosis7 mm
diameter and3 cm in length
Stenosis  7 mm diameter
and 3 cm in length
More than one focal
stenosis  7 mm diameter
Angulation and tortuosity
Iliac tortuosity index (
) 
  1.25 1.25  
  1.5 1.5  
  1.6 
  1.6
Iliac angle () 160° to 180° 121° to 159° 90° to 120°  90°
Iliac artery sealing zone
Length (L) L  30 mm 20  L  30 mm 10  L  20 mm L  10 mm
Diameter (d) d  12.5 mm 12.5  d  14.5 mm 14.5  d  17 mm d  17 mm
IIA, Internal iliac artery; IMA, inferior mesenteric artery.
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for each characteristic—and they are graded for each iliac
segment (ipsilateral and contralateral to the main device,
common, and external), unless otherwise specified.
Definitions relevant to the common and external
iliac artery segments. Calcification is scored as follows: 0,
no calcification; 1, scattered calcifications over 25% or less
of the segment length; 2, between 25% and 50% of the
segment length; 3, more than 50% of the segment length
calcified or circumferential at any level.
Iliac diameter and the presence or absence of stenotic
segments will impact device access, attachment site durabil-
ity, and sealing. For example, iliac aneurysms may affect the
durability of the attachment or seal (see sealing zone be-
low), and iliac stenoses may affect delivery device access or
endograft patency. Thus, grading is based on a consider-
ation of both a representative diameter (d) and the extent of
occlusive disease, as follows: 0, d  10 mm with no occlu-
sive disease; 1, 8  d  10 mm with no stenosis 7 mm
diameter or3 cm long; 2, 7 d 8 mm or any diameter
with a focal stenosis7 mm diameter and3 cm in length;
3, any one of the following—d 7 mm, stenosis7 mm in
diameter and 3 cm in length, or more than one focal
stenosis 7 mm in diameter.
The iliac tortuosity index (
) is defined as 
  L1/L2
where L1 is the distance along the central lumen line
between the common femoral artery and the aortic bifur-
cation and L2 is the straight-line distance from the common
femoral artery and the aortic bifurcation (Fig 1, A). The
iliac angle () is the most acute angle in the pathway
between the common femoral artery and the aortic bifur-
cation. Ideally, both the iliac angle and iliac tortuosity index
are measured from spatially-correct three-dimensional
data. They are scored as follows: 0, 
 1.25 or an iliac angle
() between 160° and 180°; 1, 1.25  
  1.5 or 
between 121° and 159°; 2, 1.5 
 1.6 or  between 90°
and 120°; 3, 
  1.6 or   90°.
Iliac artery sealing zone length was measured as follows:
0, L  30 mm; 1, 20  L  30 mm; 2, 10  L  20 mm;
3, L  10 mm. Iliac artery sealing zone diameter was
measured as follows: 0, d  12.5 mm; 1, 12.5  d  14.5
mm; 2, 14.5  d  17 mm; 3, d  17 mm.
Definitions relevant to the internal iliac artery and
pelvic collaterals. Internal iliac artery patency may affect
outcomes related to the preservation of pelvic perfusion,
including the development of claudication, colon ischemia,
paraparesis, or paraplegia. Therefore, categorization and grad-
ing is based on vessel patency and the presence of occlusive
disease. Pelvic perfusion should be graded after all maneu-
vers leading to endograft deployment to account for inten-
tional or inadvertent occlusion of the hypogastric arteries.
Pelvic perfusion is scored as follows: 0, patent hypogas-
tric arteries bilaterally, no occlusive disease; 1, unilateral
intentional, inadvertent, or chronic hypogastric artery oc-
clusion and no significant occlusive disease in the remaining
single patent hypogastric artery; 2, unilateral intentional,
inadvertent, or chronic hypogastric artery occlusion plus
significant occlusive disease (50% stenosis) in the remain-
ing single patent hypogastric artery or one of its major
branches; 3, bilateral hypogastric artery occlusion.
Categorization to yield anatomic subscores grading
risk for access failure or endograft limb obstruction
For studies investigating the risk of access failure or
endograft limb obstruction, the tortuosity, diameter, and
degree of calcification along the entire deployment pathway
may influence the risk of these periprocedural complica-
tions. Thus, a calculated score to stratify the risk of access
failure or endograft limb obstruction is proposed that con-
sists of the sum of scores grading the diameter, calcification,
and tortuosity of the entire ileofemoral artery pathway. A
30-point maximum scale is generated that can be divided
by 10 to yield an anatomic severity score on a 3-point scale.
Fig 1. Definitions pertaining to angulation and tortuosity of the aortic neck and iliac arteries (A) and body of the
aneurysm (B).
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Anatomic subscores can also be reported separately for
ipsilateral and contralateral pathways (15-point scale), so
those factors that influence either the main device or the
contralateral limb, where applicable, can be evaluated. In
this case, scores for either ipsilateral or contralateral path-
ways can be divided by 5 to yield an access-related anatomic
severity score on a 3-point scale.
Categorization to yield an anatomic score grading the
risk of embolization
For studies focused on the risk of embolization, the
tortuosity, angulation, and extent of intraluminal thrombus
along the entire deployment pathway may influence the risk
of periprocedural embolization. Thus, a calculated score to
stratify the risk of embolization is proposed that consists of
the sum of scores grading iliac and aortic tortuosity and
thrombus load. As an example, if catheter manipulation is
performed along both iliac pathways, in the presence of
bilateral common iliac artery aneurysms (2 cm), grading
would be performed using an 18-point maximum scale that
includes grades for aortic tortuosity (0-3) and thrombus
(0-3), right iliac tortuosity (0-3), and thrombus (0-3), as
well as left iliac tortuosity (0-3) and thrombus (0-3). The
summed score should be divided by 6 to yield an emboli-
zation-related anatomic severity score on a 3-point scale.
Categorization to yield an anatomic score grading the
risk of endoleak
For investigations that are directed at characterizing
failure of aneurysm exclusion caused by endoleak or endo-
tension, morphologic characteristics of the aortic neck,
aneurysm, and iliac arteries may influence this phenome-
non. Thus, a calculated score to stratify the risk of failed
aneurysm exclusion is proposed that consists of the sum of
scores grading the following: (1) aortic neck (12-point
maximum); (2) iliac artery sealing zone (6-point maximum
per iliac); and (3) aortic branch vessels (3-point maximum).
In the case of a bifurcated endograft, as an example, grading
of endoleak risk would be performed on a 27-point scale.
The summed score should be divided by 9 to yield an
endoleak-related anatomic severity score on a 3-point scale.
Categorization to yield an anatomic score grading the
risk of a “failed deployment”
Deployment failure can be caused by various factors,
such as access failure of the delivery device, proximal en-
doleak requiring immediate conversion to open repair,
vessel injury requiring conversion, or inability to remove
the delivery device after successful deployment of the stent-
graft itself. Thus, a calculated score to stratify the risk of
deployment failure is proposed that consists of the sum of
scores grading the following: (1) aortic neck; (2) aortic
angulation and tortuosity; and (3) diameter, calcification,
and tortuosity of the entire ileofemoral artery pathway.
GLOBAL SCORING SYSTEM FOR ENDOGRAFT
REPAIR: COMBINED USE OF COMORBIDITY
AND ANATOMIC SEVERITY SCORING SYSTEMS
Total morbidity and mortality during the perioperative
period are influenced by both comorbid medical conditions
and anatomic factors that influence the risk of failed deploy-
ment, embolization, and complications related to pelvic
ischemia. Thus, in providing a global scheme for grading
risk of major morbidity and mortality, it is recommended
that a calculated score be comprised by the weighted addi-
tion of the following: (1) medical comorbidity severity
score; and (2) anatomic severity scores related to the pre-
sumed risk for (a) failure of device deployment, (b) pelvic
ischemia, and (c) embolization (Table IV). As described,
each of these subscores can be graded using a 0 to 3 scale.
In recognition of the dominant roles of medical comorbid-
ity and anatomic factors that affect the risk of failed deploy-
ment, quadruple weighting is applied to these scores. The
pelvic ischemia score is single. Risk of clinically relevant
embolization may increase with the introduction of low-
profile percutaneous systems. However, currently the risk
of significant embolization appears to be low and is singly
weighted. The maximum allowable combined global sever-
ity score using this scheme is 30. Thus, scores can be divided
by 10 to yield a Global Severity Score on a 3-point scale. It is
anticipated that continued experience with endovascular an-
eurysm repair will help to further refine factor weighting.
Nevertheless, in the absence of prospective randomization,
risk stratification provides a means, however limited, for ratio-
nal comparison of disparate study populations.
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Table IV. Global scoring system for stratifying the risk
of major morbidity and mortality after endograft repair
Risk factor Weighting Score
Combined medical comorbidity 4 12
Anatomic factors that influence failed deployment 4 12
Pelvic ischemia 1 3
Embolization 1 3
Maximum score* 30
*Divide by 10 to restore 3 point scale.
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